A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept
Clinical trial NCT01339481 · COMPLETED
Trial details
- NCT number
- NCT01339481
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-02-01
- Primary completion
- 2011-10-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.